Houlihan Lokey Advises Nova Metrix

Houlihan Lokey is pleased to announce the successful sale of FISO Technologies Inc. (“FISO” or the “Company”), a subsidiary of Nova Metrix LLC ("Nova Metrix"), to Resonetics LLC ("Resonetics"), a portfolio company of GTCR. The transaction closed on November 5, 2021.

FISO is a market-leading developer and manufacturer of fiber optic sensors and readout units for use in a variety of mission-critical medical and power applications. The Company utilizes proprietary fiber optic expertise to develop products for highly specified and complex customer requirements. FISO is the partner of choice for leading blue-chip medical OEMs with significant expertise in cardiac applications, patient monitoring, women’s health, and many others. The Company has earned a superior reputation for quality, reliability, and technical leadership. Headquartered in Quebec City, Canada, FISO has over 90 employees across two manufacturing facilities.

Nova Metrix is the world's leading provider of geotechnical, environmental, and materials testing instruments, sensors, software, and consumables serving the structural health, construction, civil engineering, and energy markets. With a global reach into over 90 countries, Nova Metrix and its associated brands continue to be the largest independent geotechnical instrumentation manufacturer and leading provider of fiber optic solutions and technologies. Founded in 2009, Nova Metrix is headquartered in Wakefield, Massachusetts, and a portfolio company of Battery Ventures, Commonwealth Capital, and Ascent Venture Partners.

Founded in 1987, Resonetics is a pioneer in precision micro-manufacturing and provides contract manufacturing services to the medical device industry. Resonetics is a recognized leader in laser processing, centerless grinding, nitinol processing, thin-wall stainless steel and precious metal tubing, photochemical machining, and other critical machining services.

GTCR is a Chicago-based private equity firm focused on investing in growth companies in the Growth Business Services, Technology, Media & Telecommunications, Healthcare and Financial Services & Technology industries. Since its inception, GTCR has invested more than $20 billion in over 250 companies.

Houlihan Lokey served as the exclusive sellside financial advisor to Nova Metrix LLC and assisted in marketing, structuring, and negotiating the transaction on their behalf. The transaction highlights Houlihan Lokey’s leadership in the industrial technology and medical device sectors and further solidifies Houlihan Lokey as a leading advisor on complex transactions.